LID.L Regulatory News (LID)

21 Mar 2007 07:00

For Immediate Release 21st March 2007 LiDCO Group Plc ("the Company") DEMONSTRATION OF NEW REMOTE HEMODYNAMIC MONITORING PRODUCT - LIDCOLIVE

LiDCO, the UK based, AIM-quoted cardiovascular monitoring company, today announces the successful demonstration of its new remote monitoring software product LiDCOlive.

Background to the LiDCOlive market requirement.

The number of monitored beds in hospitals is steadily increasing and now represents 10% of all in-patient beds and approximately 30% of a hospital's revenues. Hemodynamic monitoring guided fluid and drug therapy enables the maintenance of key physiological parameters such cardiac output and oxygen delivery, thereby significantly reducing complications and costs associated with treatment of high-risk patients. The growing shortage of the highly skilled intensive care staff necessary to care for these patients has created a requirement for a monitoring technology that not only provides real time hemodynamic data but also allows the more efficient use of existing clinical staff's expertise.

The LiDCOlive Product - towards the `virtual ICU'.

One way of achieving this is to take both the patient data and monitor display to the clinician irrespective of physical location. LiDCO has therefore developed a software product called LiDCOlive that can display the LiDCOplus Monitor trend screen and real time patient data on any PC or laptop anywhere - in or out of the hospital. The requirement is that the customer has a LiDCOplus Monitor at the patient's bedside that is connected to the hospital network and then on to the internet. The clinician can then log on externally to the hospital's server with a standard PC and see exactly the same data and screen display as the nurse at the bedside. The clinician and nurse can then discuss potential treatment approaches and both immediately and simultaneously see the effects of their agreed change in fluid or drug therapy. This `virtual ICU' approach using LiDCO's technology has the potential to considerably improve the care of high-risk patients and make savings to hospitals budgets. The LiDCOlive was demonstrated both in Japan (Kobe) during the Japanese Intensive Care Society meeting and in a critical care meeting in Brno, Czech Republic during the first week of March. At both meetings patients were monitored remotely, with live patient data being sent via the internet from the University Hospital in Olomouc, Moravia and Frimley Park Hospital, Surrey, UK.

Dr. Loua Shaikh of the Department of Critical Care Medicine, Frimley Park Hospital, UK said:

"We are delighted to be the first hospital to implement the LiDCOlive remote patient viewing software. In the critical care environment the ability to remotely monitor a patient's hemodynamic data represents a significant step forward. With remote access to LiDCO's advanced minimally invasive monitoring technology we are able to assist colleagues at the bedside to make the best treatment decisions for our patients. Clearly the ability to see LiDCO's advanced user interfaces from a remote PC as if one were at the bedside makes treatment decisions much more meaningful. One now has the ability to solicit remote expert opinion as if they were with you in the intensive care unit. In terms of patient care the impact of time and distance on the delivery of experience and expert knowledge, to the bedside are considerably diminished."

The technology will be demonstrated at the ISICEM in Brussels on the 27th to 30th March, with the LiDCOlive data being sent from a hospital in the Czech Republic in combination with live video footage of the bedside. The LiDCOlive product is scheduled for wider clinical release towards the last quarter of 2007.

- ENDS -

For more information please contact:

LiDCO Group Plc Tel: +44 (0)20 7749 1500 Terry O'Brien - Chief Executive

Buchanan Communications Tel: +44 (0)20 7466 5000 Tim Anderson, James Strong Notes for EditorsAbout LiDCO Group Plc

LiDCO is a UK-based AIM-traded developer, manufacturer and leading supplier of minimally invasive, computer-based hemodynamic monitoring equipment and disposables used primarily for the management of critical care and cardiovascular risk hospital patients. Use of LiDCO's technology has been shown to significantly reduce the complications (particularly infections) and costs associated with major surgery. The technology was invented in the Department of Applied Physiology based at St Thomas' Hospital, London.

The Company's manufacturing facility is in Hoxton, London and its current products are:

* LiDCOplus and PulseCO monitors: computer-based platforms for displaying a range of real-time, continuous hemodynamic parameters including cardiac output, oxygen delivery and fluid volume; * LiDCO disposables: used in conjunction with the LiDCOplus Monitor to accurately determine cardiac output in a minimally-invasive manner. * LiDCOview - software product for use on a PC: designed to aide clinical audit, teaching and research activities.

Distribution Network:

The Company has now achieved registration of its products in 14 markets in Europe, the USA, Brazil and Japan. It sells direct in the UK and USA, and elsewhere through a worldwide network of specialty critical care distributors.